Literature DB >> 1517655

Tissue plasminogen activator, plasminogen activator inhibitor, and other parameters of fibrinolysis in the early stages of taurocholate acute pancreatitis in rats.

G Rydzewska1, S Kosidlo, A Gabryelewicz, A Rydzewski.   

Abstract

It is well known that fibrinolytic activity in the early stages of acute experimental pancreatitis (AEP) as assessed by euglobulin lysis time (ELT) is depressed. The aim of this study was to evaluate changes in the fibrinolytic system in the early stages of taurocholate AEP in rats. Tissue plasminogen activator (t-PA) activity, plasminogen activator inhibitor 1 (PAI-1) activity, plasminogen, alpha 1 proteinase inhibitor (alpha 1 PI), alpha 2 antiplasmin (alpha 2 AP), antithrombin III (AT III), fibrinogen, and ELT were measured 0.5, 1, 3, and 6 h after the induction of taurocholate AEP in rats, as well as in sham-operated animals and the control group, which was not submitted to any operation. T-PA activity decreased significantly after 3 and 6 h of AEP; PAI activity had a time course reverse to t-PA and was parallel to alpha 1 PI activity. ELT was slightly prolonged after 0.5, 1, and 3 h, whereas alpha 2 AP activity and plasminogen levels increased significantly; AT III activity was increased after 1 h in comparison to control group. Sham operation caused nonsignificant changes in fibrinolysis. Increase of PAI activity and decrease of t-PA could be a reasonable explanation for inhibited plasma euglobulin fibrinolytic activity noted in the early period of AEP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517655     DOI: 10.1007/bf02924181

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  26 in total

1.  Fibrinolysins of human plasma; a comparison of fibrinolytic plasma from normal subjects and from cadaver blood with plasmin prepared by activation with chloroform.

Authors:  E BIDWELL
Journal:  Biochem J       Date:  1953-10       Impact factor: 3.857

2.  [Pancreas and hemostasis].

Authors:  A Gabryelewicz
Journal:  Pol Arch Med Wewn       Date:  1977-08

3.  Activation of blood clotting and inhibition of fibrinolysis in acute pancreatitis.

Authors:  A Gabryelewicz; S Niewiarowski
Journal:  Thromb Diath Haemorrh       Date:  1968-12-31

4.  Heparin and protease inhibitors in the prevention of experimental acute pancreatic necrosis in dogs.

Authors:  A Gabryelewicz; S Niewiarowski; J Prokopowicz; J Chlebowski
Journal:  Digestion       Date:  1969       Impact factor: 3.216

5.  Heparin and protease inhibition. II. The role of heparin in the ATIII inactivation of thrombin, plasmin, and trypsin.

Authors:  G F Smith; J L Sundboom
Journal:  Thromb Res       Date:  1981 Apr 1-15       Impact factor: 3.944

6.  Plasminogen activator inhibitor (PAI-1) in plasma and platelets.

Authors:  N A Booth; A J Simpson; A Croll; B Bennett; I R MacGregor
Journal:  Br J Haematol       Date:  1988-11       Impact factor: 6.998

7.  Delayed elimination of fibrin from the lungs in rats given alpha 2-antiplasmin.

Authors:  G Carlin; M Einarsson; T Saldeen
Journal:  Thromb Haemost       Date:  1981-12-23       Impact factor: 5.249

8.  Human protease nexin-I. Further characterization using a highly specific polyclonal antibody.

Authors:  E W Howard; D J Knauer
Journal:  J Biol Chem       Date:  1986-01-15       Impact factor: 5.157

9.  Plasminogen activator in normal subjects after exercise and venous occlusion: t-PA circulates as complexes with C1-inhibitor and PAI-1.

Authors:  N A Booth; E Walker; R Maughan; B Bennett
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

10.  Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states.

Authors:  E K Kruithof; A Gudinchet; F Bachmann
Journal:  Thromb Haemost       Date:  1988-02-25       Impact factor: 5.249

View more
  4 in total

1.  Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats.

Authors:  P Kruse; E Hage; A Lasson
Journal:  Int J Pancreatol       Date:  1999-04

2.  Shock releases bile acid inducing platelet inhibition and fibrinolysis.

Authors:  Gregory Wiener; Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Scott Diamond; Shu Zhu; Angelo D'Alessandro; Anirban Banerjee
Journal:  J Surg Res       Date:  2015-01-29       Impact factor: 2.192

3.  Decreased inflammation and improved survival with recombinant human activated protein C treatment in experimental acute pancreatitis.

Authors:  Guido Alsfasser; Andrew L Warshaw; Sarah P Thayer; Bozena Antoniu; Michael Laposata; Kent B Lewandrowski; Carlos Fernández-del Castillo
Journal:  Arch Surg       Date:  2006-07

Review 4.  The Interplay between Inflammation, Coagulation and Endothelial Injury in the Early Phase of Acute Pancreatitis: Clinical Implications.

Authors:  Paulina Dumnicka; Dawid Maduzia; Piotr Ceranowicz; Rafał Olszanecki; Ryszard Drożdż; Beata Kuśnierz-Cabala
Journal:  Int J Mol Sci       Date:  2017-02-08       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.